World Cord Blood Day 2017 - Global Events and Free Virtual Conference

25 Oct, 2017 by  David Murphy

As the official sponsor of World Cord Blood Day 2017, we would like to cordially invite you to join us on November 15th to help promote cord blood awareness around the globe. The purpose of World Cord Blood Day is to educate expectant parents and health professionals about the current applications for this non-controversial source of stem cells and to highlight exciting research happening in this field of medicine. 

World Cord Blood Day will feature a free virtual conference. The program will include introductory presentations for the public as well as academic lectures specifically designed for health professionals, led by renowned researchers and transplant doctors.

Organized by Save the Cord Foundation, World Cord Blood Day is officially sponsored by Quick Specialized Healthcare Logistics. Inspiring Partners for this inaugural event include the Cord Blood Association, Be the Match (NMDP), World Marrow Donor Association (WMDA-Netcord), AABB and FACT. For more information, please visit: 


In 1988 in France, Dr. Eliane Gluckman performed the world's first cord blood transplant. This event set in motion a revolution in the medical world.  To date there have been over 35,000 cord blood transplants worldwide. Currently, cord blood is being used to treat over 80 different life-threatening diseases such as leukemia, lymphoma and sickle cell anaemia.  It is also proving critical to new areas of regenerative medicine to potentially treat spinal cord injuries, cerebral palsy, autism, type 1 diabetes and much more.  We are just beginning to discover its full potential.


  • Cord blood is the blood left in the umbilical cord and placenta following the birth of a child
  • Cord blood is a potent and non-controversial source of stem cells
  • Unlike embryonic stem cells (taken from an embryo), cord blood is not controversial or unethical in any way because it is only collected post-birth
  • Cord blood has no political or religious issues
  • Collection of cord blood poses no risks to the mother or baby
  • The collection of cord blood does not interfere with the birthing process
  • Cord blood stem cells are currently being used to treat and cure more than 80 life-threatening illnesses, including many cancers, immune deficiencies and genetic disorders
  • Cord blood has many distinct advantages over bone marrow
  • Cord blood is easier to collect, store and access quickly for a transplant
  • There is significantly less risk of GvHD (Graft versus Host Disease) with cord blood as opposed to bone marrow
  • Recent studies have shown that there is less risk of a relapse for certain diseases


For more information, please visit:

About David Murphy
Executive Vice President Life Science Solutions

David Murphy is a 30 year veteran of The Quick Group of Companies, holding various leadership roles in Quick's Life Science division. Over the past 8 years, David has served as Executive Vice President of Quick's Life Science... Read more.

Recent Blog Posts: